Last reviewed · How we verify

NCT07283627: MBT & cancer

Exploring the Evolution of Quality of Life and Emotional Distress Among Cancer Patients Participating in Mind-body Therapies

ENROLLING BY INVITATION Last updated 24 December 2025
What this trial tests

trial in Cancer in 150 participants. Enrolling by invitation.

Timeline
1 December 2025
Primary endpoint
1 January 2027
1 January 2027

Quick facts

Lead sponsorLa Tour Hospital
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment150
Start date1 December 2025
Primary completion1 January 2027
Estimated completion1 January 2027
Sites1 location across Switzerland

Conditions studied

Sponsor

La Tour Hospital

Who can join

18 and older, any sex, with Cancer or Mind-Body Therapies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cancer incidence is increasing worldwide, and although survival rates have improved thanks to advances in treatment and early detection, many patients continue to experience reduced quality of life (QoL), anxiety, depression, and distress. Mind-body therapies (MBTs)-including mindfulness, laughter yoga, and art therapy-are increasingly integrated into supportive oncology care. Evidence suggests these therapies may improve psychosocial well-being; however, existing research often suffers from methodological limitations, small samples, and limited generalizability. The OTIUM centers in Geneva and Meyrin offer structured MBT programs to cancer patients. This project aims to evaluate the evolution of QoL and emotional distress in patients participating in one of these therapies, using validated patient-reported outcome measures (PROMs).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other La Tour Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07283627.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing